Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Generex Biotechnology expands its patent portfolio in North & South America

07 Mar 2008 - Generex Biotechnology Corporation announced that it has received new patents in Canada and Argentina. The Canadian Intellectual Property Office has granted the Company a new patent titled "Mixed Micellar Pharmaceutical Delivery System and Method of Preparation." The patent contains process, formulation, and use claims to a mixed micellar pharmaceutical formulation for buccal administration.
 
The National Institute of Industrial Property of Argentina has granted the Company a new patent titled "Proteinic Drug Delivery System Using Membrane Mimetics." The patent contains process and formulation claims to a mixed liposome pharmaceutical formulation.
 
"We are pleased to continue to expand our patent portfolio, particularly in Canada as we move forward with the regulatory process for Generex Oral-lynT once the Phase III pivotal study is completed at global sites," said Rose C. Perri, the Company's Chief Operating Officer.
 
Generex currently holds an aggregate of 125 patents worldwide (21 of which are United States Patents) and has an aggregate of 90 patent applications pending in various jurisdictions.